Henrich A[au] - Search Results

Year	Number of Results
1981	1
1984	1
1992	1
1998	2
2000	3
2004	1
2005	1
2009	2
2010	4
2011	1
2012	1
2013	3
2014	1
2015	2
2016	3
2017	1
2019	1
2020	2
2021	4
2023	0

1

Engineering microbial electrocatalysis for chemical and fuel production.

Rosenbaum MA, Henrich AW. Rosenbaum MA, et al. Among authors: henrich aw. Curr Opin Biotechnol. 2014 Oct;29:93-8. doi: 10.1016/j.copbio.2014.03.003. Epub 2014 Apr 5. Curr Opin Biotechnol. 2014. PMID: 24709348 Review.

2

PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT.

Henrich A, Juif PE, Dingemanse J, Krause A. Henrich A, et al. J Pharmacokinet Pharmacodyn. 2021 Apr;48(2):213-224. doi: 10.1007/s10928-020-09728-7. Epub 2021 Jan 2. J Pharmacokinet Pharmacodyn. 2021. PMID: 33389549 Clinical Trial.

3

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y₁₂ receptor between selatogrel and oral P2Y₁₂ antagonists.

Henrich A, Claussen CH, Dingemanse J, Krause A. Henrich A, et al. CPT Pharmacometrics Syst Pharmacol. 2021 Jul;10(7):735-747. doi: 10.1002/psp4.12641. Epub 2021 May 30. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33955698 Free PMC article.

4

Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia.

Henrich A, Joerger M, Kraff S, Jaehde U, Huisinga W, Kloft C, Parra-Guillen ZP. Henrich A, et al. J Pharmacol Exp Ther. 2017 Aug;362(2):347-358. doi: 10.1124/jpet.117.240309. Epub 2017 Jun 9. J Pharmacol Exp Ther. 2017. PMID: 28600397

5

A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker.

Huynh C, Henrich A, Strasser DS, Boof ML, Al-Ibrahim M, Meyer Zu Schwabedissen HE, Dingemanse J, Ufer M. Huynh C, et al. Among authors: henrich a. Clin Pharmacol Ther. 2021 Jun;109(6):1648-1659. doi: 10.1002/cpt.2154. Epub 2021 Feb 15. Clin Pharmacol Ther. 2021. PMID: 33406277

6

Expanding the molecular toolkit for the homoacetogen Clostridium ljungdahlii.

Molitor B, Kirchner K, Henrich AW, Schmitz S, Rosenbaum MA. Molitor B, et al. Among authors: henrich aw. Sci Rep. 2016 Aug 16;6:31518. doi: 10.1038/srep31518. Sci Rep. 2016. PMID: 27527841 Free PMC article.

7

The Case for an Unblinded Modeler in Early Clinical Development.

Krause A, Henrich A, Dingemanse J. Krause A, et al. Among authors: henrich a. J Clin Pharmacol. 2020 Mar;60(3):369-377. doi: 10.1002/jcph.1526. Epub 2019 Sep 25. J Clin Pharmacol. 2020. PMID: 31552685

8

Coating of ß-tricalcium phosphate scaffolds-a comparison between graphene oxide and poly-lactic-co-glycolic acid.

Ardjomandi N, Henrich A, Huth J, Klein C, Schweizer E, Scheideler L, Rupp F, Reinert S, Alexander D. Ardjomandi N, et al. Among authors: henrich a. Biomed Mater. 2015 Aug 4;10(4):045018. doi: 10.1088/1748-6041/10/4/045018. Biomed Mater. 2015. PMID: 26238604

9

Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing: Results from a Thorough QT Study Using Concentration-QT Analysis.

Schilling U, Henrich A, Muehlan C, Krause A, Dingemanse J, Ufer M. Schilling U, et al. Among authors: henrich a. Clin Drug Investig. 2021 Aug;41(8):711-721. doi: 10.1007/s40261-021-01062-1. Epub 2021 Jul 31. Clin Drug Investig. 2021. PMID: 34331678 Clinical Trial.

10

Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death.

Conradt L, Henrich A, Wirth M, Reichert M, Lesina M, Algül H, Schmid RM, Krämer OH, Saur D, Schneider G. Conradt L, et al. Among authors: henrich a. Int J Cancer. 2013 May 15;132(10):2248-57. doi: 10.1002/ijc.27916. Epub 2012 Nov 26. Int J Cancer. 2013. PMID: 23115126 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results